SYNOPSIS Staining with naphthol AS phosphate and Fast Blue BB salt has been used for the estimation of neutrophil alkaline phosphatase (NAP) scores in patients with chronic granulocytic leukaemia (CGL). The very low scores found at diagnosis rise when the disease is treated, and there is some inverse correlation between the NAP score and the absolute neutrophil count. Patients treated intensively developed high NAP scores. Elective splenectomy performed during the chronic phase of CGL is followed by a pronounced but transient neutrophilia and a concurrent striking rise in the NAP score. Similar changes were observed in patients without CGL who underwent splenectomy. These observations can be explained by assuming that newly formed neutrophils in CGL have a normal content of NAP but are rapidly sequestered in non-circulating extramedullary pools, whereas the circulating neutrophil with a typically low NAP content is a relatively aged cell which has lost enzyme activity. In subjects with or without CGL, removal of the spleen, a major site of such pooling, temporarily permits the circulation of newly formed neutrophils but eventually other organs assume the sequestering functions of the spleen. Thus the aberrations of NAP score seen in CGL might be attributable not to an intrinsic cellular defect but to an exaggeration of the granulocyte storage phenomena which also occur in subjects without CGL.
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Almost 30 years ago, Gomori's histochemical method for the demonstration of alkaline phosphatase was applied to the localization of the enzyme in human peripheral blood and bonemarrow cells: it appeared to be confined to mature neutrophils and band forms (Wachstein, 1946) . Wachstein described increased enzyme activity in polycythaemia rubra vera, some cases of myelosclerosis, and in leukaemoid reactions. He was also the first to report a pronounced decrease in activity in most cases of chronic granulocytic leukaemia (CGL), and this difference has been used as an aid in the differentiation of CGL from the above conditions (Koler, Seaman, Osgood, and Van Bellinghen, 1958; Mitus, Bergna, Mednicoff, and Dameshek, 1958) . Reduced levels of the enzyme are also observed in paroxysmal nocturnal haemoglobinuria and infectious mononucleosis (Tanaka, Valentine, and Fredricks, 1960; Lewis and Dacie, 1965 Increased NAP activity has been observed in myeloproliferative disorders, infections, after administration of adrenocortical steroids (Strausz, Kekes, and Szebeni, 1965) , in carcinomatosis (Lille-Szyszkowicz, Gabay, Saracino, and Bourdin, 1966) , and in Hodgkin's disease (Bennett, Nathanson, and Rutenburg, 1968; Sforza, De Somoza, and Morgenfeld, 1971; Simmons, Spiers, and Fayers, 1973) . In CGL, a low NAP value is almost invariable in untreated patients (Rosner, Schreiber, and Parise, 1972) , and in addition, the enzyme purified from CGL neutrophils is reported to have a lower specific activity than NAP from normal cells (Bottomley, Lovig, Holt, and Griffin, 1969) : the mechanism of these changes is unknown. We have studied NAP activity in patients with CGL before and during treatment, and during this investi-517 A. S. D. Spiers, A. Liew, and A. G. Baikie gation found an unexpected and striking alteration of the NAP level following splenectomy.
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Patients and Methods
PATI ENTS
The 18 patients studied had haematologically typical CGL in its chronic phase, and in all the Philadelphia (Ph') chromosome was demonstrated in bone marrow cells. Fourteen of the 18 patients were untreated when first studied and 15 were studied during their initial chemotherapy. These 15 patients were splenectomized, and eight were studied within the 14 days after splenectomy. In 12 of the 15, the NAP was estimated six months after splenectomy. Thirteen patients were treated with busulphan while five received thioguanine for initial therapy as part of a clinical trial. The splenectomies were performed after the induction of disease remission, as part of a trial of elective splenectomy early in the course of CGL (Baikie, 1968; Spiers, 1973 (1, 0D/p1) the mean NAP score for 15 patients was 32-0; in two patients the NAP score was normal and in three it was above normal (fig 1) . The five highest scores were observed in patients who had had intensive treatment with thioguanine, and the highest individual reading (170) was observed in the patient with the lowest neutrophil count (200 per ,ul) . Figure 2 further illustrates the same correlation. Fifty-five observations were made in the 18 patients studied at diagnosis and/or before splenectomy was performed. Although low NAP scores were most often associated with an increased neutrophil count, they were also seen on six occasions when the neutrophil count was normal. On the other hand, normal or high NAP scores were never found with an increased absolute neutrophil count. Figure 3 shows the changes in NAP score and absolute neutrophil count in a patient with CGL who was followed for almost two years. The NAP score remained above or within the normal range for nearly one year: consistently low NAP scores in the second year were accompanied by normal or elevated neutrophil counts, and the reciprocity of the two curves is readily apparent.
EFFECTS OF SPLENECTOMY UPON NAP SCORE
Fifteen patients whose CGL was in its chronic phase underwent elective splenectomy but in the first Neutrophil alkaline phosphatase score in chronic granulocytic leukaemia trolled by therapy. This change is inconstant; thus Rosner's group found restoration of a normal NAP score in only four of 16 patients, and in these four the score was not normal in every period of remission which they experienced. In our patients, the mean and median NAP scores were higher after drug treatment than before it, but in 10 patients the score was still subnormal (fig 1) . Our finding of a loose inverse correlation between absolute neutrophil count and NAP score (fig 2) accords well with the observations of others that successful treatment of CGL has an inconstant association with an increase in previously depressed NAP scores. In our patients, restoration of the NAP score was not associated with a greatly increased proportion of neutrophils with NAP activity graded as 3 or 4-these remained uncommon-but rather with a decrease in the proportion of neutrophils with zero activity. It therefore appears that drug treatment which corrects the neutrophilia in CGL may selectively affect that part of the neutrophil population which lacks alkaline phosphatase.
Our finding in a series of patients of a consistent striking increase in NAP score immediately after splenectomy has not to our knowledge been reported previously. Stewart (1974) noted an elevated NAP score in a single patient with CGL studied five days after splenectomy. The rise in NAP score in our patients accompanied a marked rise in neutrophil count, which is the reverse situation to the smaller increase in NAP score sometimes seen when CGL is treated with busulphan. The rise in NAP score after splenectomy was, as with drug therapy, associated with a decrease in the proportion of NAP-negative neutrophils rather than an increase in the numbers of cells with scores of 3 or 4 units. This effect of splenectomy appears to be independent of drug therapy, since it was also observed in the patient treated by leucapheresis alone. Similar marked elevations of NAP score after splenectomy were observed in a patient with myelosclerosis and a patient with no haematological disorder, so the phenomenon is not peculiar to CGL. However, its occurrence in CGL suggests a possible mechanism for the fluctuations of NAP score in this disease.
The contradictory literature relating to the interpretation of NAP values in CGL was reviewed by Pedersen and Hayhoe (1971a) . Hypotheses which relate the loss of enzyme activity directly to possession of the Ph' chromosome (Alter, Dobkin, Pourfar, Rosner, and Lee, 1963) seem incompatible with the return of NAP activity in diffusion chamber cultures (Chikkappa, Boecker, Borner, Carsten, Conkling, Cook, Cronkite, and Dunwoody, 1973) and in vivo during remission of CGL while the bonemarrow cells remain Ph'-positive (Tough, Jacobs, Court Brown, Baikie, and Williamson, 1963) . Normal or increased NAP activity and persisting Ph'-positivity is also seen in some cases of CGL after acute transformation (King et al, 1962; Hammouda, Quaglino, and Hayhoe, 1964) . Other hypotheses which sought to explain elevated NAP scores in Down's syndrome and decreased scores in CGL as dose-effects of the NAP gene(s) were early seen to be unsatisfactory (King et al, 1962) and later became untenable with the demonstration (O'Riordan, Robinson, Buckton, and Evans, 1971) that the Ph' anomaly involves a chromosome different from that which is present in triplicate in Down's syndrome.
The interpretation advanced by Hook and Engel (1964) seems to us to fit best all the observations including those we now report for the first time. They suggested that low NAP scores in CGL were due to the accumulation of ageing neutrophils with reduced enzyme activity. Such cells diluted the younger neutrophils which possessed NAP activity and thereby lowered the NAP score, even though the absolute number of NAP-carrying neutrophils might be normal. This interpretation is compatible with the prolonged intravascular life-span of mature granulocytes in CGL (Galbraith, 1966) . Recent studies by Kelemen (1973) , and our own observations of the effects of splenectomy upon the NAP score in CGL, corroborate the interpretation of Hook and Engel. Kelemen found in cases of druginduced neutropenia and idiopathic aplastic anaemia that the NAP score was high in both peripheral blood and bone-marrow. He suggested that when the reserve of mature granulocytes in the marrow was reduced, high NAP scores were attributable to the release of newly formed neutrophils into the circulation. When marrow granulocytes were increased, as in CGL, older neutrophils which had been stored for some time and had lost their NAP activity constituted the major element in the neutrophil population of the peripheral blood. This hypothesis is compatible with the return of NAP activity in CGL under conditions where the granulocyte reserves are reduced-for example by treatment with busulphan, during the neutrophil response to infection (Rosen and Teplitz, 1965; Finney, McDonald, Baikie, and Douglas, 1972) , or during the development of acute transformation, when the bone marrow is being replaced by undifferentiated leukaemic cells. We have observed an analogous phenomenon in patients without leukaemia who had extensi've bone-marrow invasion by lymphoma or carcinoma: a leucoerythroblastic peripheral blood picture with neutrophilia was often accompanied by elevation of the NAP score to over 300. The concept of reduced reserves of neutrophils with release of newly formed 521 522 cells which possess NAP also explains the high NAP scores we observed in our CGL patients when significant bone-marrow depression had been produced by treatment with thioguanine (fig 1) .
In untreated patients with CGL the enormously expanded mass of mature and immature granulocytic cells is accommodated in the bone marrow, peripheral blood, spleen, and in other extramedullary sites such as the liver and the pulmonary vasculature. If after their formation neutrophils progress from the bone-marrow multiplier compartment to storage pools, including those in the marrow itself (fig 5a) and finally to the peripheral blood, the great expansion of the storage pools in CGL should entail a delay in reaching the circulation as a definitive circulating cell. (Obviously those neutrophils which are made in the bone marrow and then stored in extramedullary pools must, if only transiently, pass through the circulation to reach their storage site.) In addition to the longer delay before becoming circulating cells, many of the neutrophils then remain for an abnormally long span in the blood (Galbraith, 1966) . Thus the circulating neutrophils will be predominantly elderly and have reduced NAP activity. Reduction of the total granulocytic pool by antileukaemic drugs allows the earlier release into the circulation of younger neutrophils which possess NAP activity, and also reduces the numbers of ageing neutrophils without NAP activity, so that they no longer dilute the NAP score.
When splenectomy is performed in patients with (fig 5b) . A temporary deficiency of storage space is reflected by a striking though transient neutrophilia, accompanied by an equally striking rise in the NAP score, which then declines in parallel with the peripheral blood neutrophil count. The rapid though usually incomplete return of both neutrophil count and NAP score to their pre-splenectomy levels (fig 4) suggests increased utilization of other storage compartments by way of compensation. The hypothesis that NAP activity is inversely related to the age of the neutrophil conflicts with some others previously advanced. Pedersen and Hayhoe (1971b) demonstrated that actively phagocytic CGL neutrophils are more frequently NAPpositive than non-phagocytic neutrophils. This observation and evidence of defective cytoplasmic maturation of many neutrophils in CGL (Pedersen and Hayhoe, 1971a ) led them to postulate that the low NAP score was a manifestation of cellular immaturity. However, NAP activity has been observed in band forms (Wachstein, 1946) , in immature granulocytic cells (Stewart, 1974) , in pseudo-Pelger neutrophils (Malaskova and Fuksova, 1968) , and also in true Pelger neutrophils . Thus immaturity or abnormal maturation do not necessarily preclude the possession of NAP by granulocytic cells. Pedersen and Hayhoe further suggested (1971b) that the principal site of origin of mature, phagocytic, NAP-positive neutrophils in CGL patients might be the spleen: an increased NAP score during acute transformation of CGL was attributed to a relatively higher proportion of the peripheral blood neutrophils being of splenic, rather than bone-marrow, origin. Our finding that splenectomy in CGL is consistently followed by a striking increase in the NAP score makes this hypothesis improbable.
We therefore postulate that fluctuations of the peripheral blood NAP score in CGL are due not to any intrinsic property peculiar to CGL cells, but to alterations in the size of the granulocyte storage compartments in the bone marrow, spleen, and elsewhere. The variable extent to which these compartments are affected by the disease and its treatment adequately explains the variations in NAP score seen in different patients whose disease appears on the basis of peripheral blood counts to have been controlled to the same extent. This hypothesis is strengthened by the finding of similar changes in NAP score when splenectomy is performed in patients who do not have leukaemia.
It may be better to express NAP activity in CGL not as a veighted score per 100 cells, but by some parameter which reflects change in the absolute
